Kidney Disease News and Research

RSS

A promising new therapeutic target for kidney disease

Despite nearly two million people dying of acute kidney injury every year, and tens of millions more needing treatment, no effective drug treatment for the condition is available.

7 Dec 2021

People who exercise regularly have lower risk of developing and dying from pneumonia

People who exercise regularly can reduce their risk of developing and dying from pneumonia, new research has found.

7 Dec 2021

Hospitalization trends and associated factors for COVID in 2.3 million adults in England

Researchers performed a retrospective cohort study to determine risk factors for hospitalization and mortality rates over time among COVID-19 patients.

6 Dec 2021

Prevalence of type 2 diabetes is elevated in people with a psychiatric disorder

A new study published in Diabetologia (the journal of the European Association for the Study of Diabetes (EASD)) finds that the prevalence of type 2 diabetes (T2D) is elevated in people with a psychiatric disorder compared with the general population.

30 Nov 2021

COVID-19 infections in the fully vaccinated are rare but are common in people with weak immune systems

A real-world retrospective cohort study involving nearly 1.2 million people shows COVID-19 infections in the 'fully' vaccinated are rare but are more common and severe in people with weaker immune systems.

30 Nov 2021

SARS-CoV-2 can directly invade human kidney cells, research shows

Up to 25% of patients' COVID-19 cases involve acute kidney injury—the kidneys' equivalent of a heart attack.

29 Nov 2021

Days of extreme heat associated with increased risk of emergency department visits

Extremely hot days with an average temperature of 34.4°C (93.9°F) are associated with a higher risk of emergency department visits among adults of all ages, finds a large study from the United States published by The BMJ today.

25 Nov 2021

UK's leading health charities team up to encourage vulnerable people to get COVID-19 vaccines

Some of the UK's leading health charities including the British Heart Foundation, Diabetes UK and Cancer Research UK are joining forces with the government and the NHS to encourage vulnerable people to get their COVID-19 vaccines.

25 Nov 2021

Study reveals extra burden of COVID-19 adverse events in end-stage kidney disease patients

Patients undergoing long-term dialysis, especially Black and Hispanic patients and those living in nursing homes, were severely impacted by the COVID-19 pandemic, according to a nationwide study by University of Michigan researchers.

23 Nov 2021

Advanced kidney disease associated with death for cerebral palsy patients, study reveals

Cerebral palsy and kidney disease can be deeply intertwined. In childhood, the effects of the neurodevelopmental condition – like decreased physical activity and urologic dysfunction – are risk factors for kidney disease.

17 Nov 2021

Scientists identify new gene that contributes to type 1 diabetes progression

When the pro-inflammatory pair, a receptor called CCR2 and its ligand CCL-2, get together, it increases the risk of developing type 1 diabetes, scientists report.

16 Nov 2021

Two genetic risk variants in Black individuals may exacerbate sepsis and COVID-19 severity

Two genetic risk variants that are carried by nearly 40 percent of Black individuals may exacerbate the severity of both sepsis and COVID-19, a team of researchers from the University of Pennsylvania's Perelman School of Medicine have found.

16 Nov 2021

Advanced tools for Glycobiology research

Drawing upon over 30-years’ experience of serving the glycobiology research community - AMSBIO has established a comprehensive portfolio of high-quality reagents including unique ranges of antibodies, lectins, enzymes, assay kits and standards, backed by in-depth technical support.

From AMS Biotechnology 16 Nov 2021

Simple risk score can help predict contrast-associated kidney injury after PCI

A new, updated risk score can help predict possible contrast-associated acute kidney injury (CA-AKI) among patients undergoing percutaneous coronary intervention (PCI), Mount Sinai researchers report.

15 Nov 2021

Racial or ethnic group of patients with diabetes influences prognosis of the disease

Professor and researcher of the Faculty of Nursing and Podiatry of the UV, Yasmín Ezzatvar, together with researchers from other centers, concludes that the racial or ethnic group of patients with type 1 and 2 diabetes mellitus influences the prognosis of the disease, due to differences in mortality, risk of kidney disease or risk of cardiovascular disease.

15 Nov 2021

Valve replacement surgery may be beneficial for patients with asymptomatic severe aortic stenosis

For people experiencing severe aortic stenosis who do not have symptoms or need symptom relief, early aortic valve replacement surgery may be beneficial because it reduces the risk of death, heart attack, stroke and heart failure, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2021.

15 Nov 2021

Type 2 diabetes medication works effectively, safely in patients hospitalized for acute heart failure

Adults treated with empagliflozin during hospitalization for acute heart failure experienced a clinical benefit such as increased survival, lower risk of heart failure hospital readmission and an overall improvement in their quality of life, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2021.

15 Nov 2021

COVID-19 vaccination humoral immune response in individuals with diabetes

A new study investigated the humoral immune response and side effects related to COVID-19 vaccines in individuals with type 1 diabetes and type 2 diabetes.

12 Nov 2021

Vaccinated patients hospitalized with COVID-19 in Norway spend fewer days in the hospital

A recent study looks at how mRNA vaccination affects hospitalization and ICU admission in COVID-19 breakthrough infections.

11 Nov 2021

Effectiveness of sotrovimab demonstrated in patients with mild to moderate COVID-19

In an attempt to study the safety and effectiveness of sotrovimab in more vulnerable patients suffering from mild to moderate symptoms of COVID-19, a multinational team of researchers conducted the COVID-19 Monoclonal antibody Efficacy Trial-Intent to Care Early (COMET-ICE) trial.

11 Nov 2021

Kidney Disease News and Research

A promising new therapeutic target for kidney disease

People who exercise regularly have lower risk of developing and dying from pneumonia

Hospitalization trends and associated factors for COVID in 2.3 million adults in England

Prevalence of type 2 diabetes is elevated in people with a psychiatric disorder

COVID-19 infections in the fully vaccinated are rare but are common in people with weak immune systems

SARS-CoV-2 can directly invade human kidney cells, research shows

Days of extreme heat associated with increased risk of emergency department visits

UK's leading health charities team up to encourage vulnerable people to get COVID-19 vaccines

Study reveals extra burden of COVID-19 adverse events in end-stage kidney disease patients

Advanced kidney disease associated with death for cerebral palsy patients, study reveals

Scientists identify new gene that contributes to type 1 diabetes progression

Two genetic risk variants in Black individuals may exacerbate sepsis and COVID-19 severity

Advanced tools for Glycobiology research

Simple risk score can help predict contrast-associated kidney injury after PCI

Racial or ethnic group of patients with diabetes influences prognosis of the disease

Valve replacement surgery may be beneficial for patients with asymptomatic severe aortic stenosis

Type 2 diabetes medication works effectively, safely in patients hospitalized for acute heart failure

COVID-19 vaccination humoral immune response in individuals with diabetes

Vaccinated patients hospitalized with COVID-19 in Norway spend fewer days in the hospital

Effectiveness of sotrovimab demonstrated in patients with mild to moderate COVID-19

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News